<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE267nnn/GSE267532/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mycobacterium tuberculosis</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267532</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Chemically Induced Alanine Auxotrophy of Mycobacterium tuberculosis</name><description>Utilizing a novel computational chemogenomics method to discover new antitubercular compounds, a hit compound designated TI-374 was identified with a minimal inhibitory concentration of 540 nM against M. tuberculosis H37Rv. To investigate the mechanism of action, transcriptional profiling of treated cultures was conducted by RNA-seq. Combined with computational chemogenomic target prediction, metabolomic analysis of treated cultures, nutritional suppression experiments, activity in biochemical assays against purified protein, and whole-genome sequencing of resistant mutants, this transcriptomic data is consistent with a novel mechanism of action whereby TI-374 inhibits the alanine aminotransferase annotated as aspC. This activity interferes with alanine biosynthesis, which is required for growth of the pathogen.</description><dates><publication>2026/09/24</publication></dates><accession>GSE267532</accession><cross_references><GSM>GSM8268363</GSM><GSM>GSM8268362</GSM><GSM>GSM8268361</GSM><GSM>GSM8268364</GSM><GPL>34478</GPL><GSE>267532</GSE><taxon>Mycobacterium tuberculosis</taxon><PMID>[42466413]</PMID></cross_references></HashMap>